NO174669C - Analogifremgangsmåte for fremstilling av terapeutisk aktive benzotiopyranylaminer - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive benzotiopyranylaminer

Info

Publication number
NO174669C
NO174669C NO901303A NO901303A NO174669C NO 174669 C NO174669 C NO 174669C NO 901303 A NO901303 A NO 901303A NO 901303 A NO901303 A NO 901303A NO 174669 C NO174669 C NO 174669C
Authority
NO
Norway
Prior art keywords
benzothiopyranylamines
preparation
therapeutically active
analogous process
und
Prior art date
Application number
NO901303A
Other languages
English (en)
Norwegian (no)
Other versions
NO174669B (no
NO901303D0 (no
NO901303L (no
Inventor
Alan J Hutchison
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO901303D0 publication Critical patent/NO901303D0/no
Publication of NO901303L publication Critical patent/NO901303L/no
Publication of NO174669B publication Critical patent/NO174669B/no
Publication of NO174669C publication Critical patent/NO174669C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Cosmetics (AREA)
  • Indole Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Tea And Coffee (AREA)
NO901303A 1989-03-22 1990-03-21 Analogifremgangsmåte for fremstilling av terapeutisk aktive benzotiopyranylaminer NO174669C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32694989A 1989-03-22 1989-03-22

Publications (4)

Publication Number Publication Date
NO901303D0 NO901303D0 (no) 1990-03-21
NO901303L NO901303L (no) 1990-09-24
NO174669B NO174669B (no) 1994-03-07
NO174669C true NO174669C (no) 1994-06-15

Family

ID=23274473

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901303A NO174669C (no) 1989-03-22 1990-03-21 Analogifremgangsmåte for fremstilling av terapeutisk aktive benzotiopyranylaminer

Country Status (22)

Country Link
US (1) US5071858A (fr)
EP (1) EP0389425B1 (fr)
JP (1) JPH06102657B2 (fr)
KR (1) KR900014357A (fr)
AT (1) ATE121740T1 (fr)
AU (1) AU632318B2 (fr)
CA (1) CA2012569A1 (fr)
DD (1) DD292913A5 (fr)
DE (1) DE69018864D1 (fr)
DK (1) DK0389425T3 (fr)
ES (1) ES2071074T3 (fr)
FI (1) FI94863C (fr)
GR (1) GR3015938T3 (fr)
HU (1) HU206205B (fr)
IE (1) IE67871B1 (fr)
IL (2) IL93814A0 (fr)
MX (1) MX19953A (fr)
NO (1) NO174669C (fr)
NZ (1) NZ233002A (fr)
PT (1) PT93515B (fr)
TW (1) TW204347B (fr)
ZA (1) ZA902168B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE136461T1 (de) * 1990-08-13 1996-04-15 Searle & Co Verwendung von heterozyklischen aminoalkoholverbindungen zur herstellung eines medikaments für die behandlung von erkrankungen des zns
FR2691149B1 (fr) * 1992-05-18 1994-07-08 Adir Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5428307A (en) * 1993-10-20 1995-06-27 Silicon Systems, Inc. Closed-loop peak detector topology
JPH0967367A (ja) 1995-06-23 1997-03-11 Suntory Ltd チオピラン誘導体
FR2739855B1 (fr) * 1995-10-13 1997-11-14 Adir Nouvelles amines heterocycliques tertiaires, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2763335B1 (fr) * 1997-05-16 2000-11-24 Adir Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20050148018A1 (en) * 1999-10-07 2005-07-07 David Weiner Methods of identifying inverse agonists of the serotonin 2A receptor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2077733B1 (fr) * 1970-02-10 1973-03-16 Roussel Uclaf
GB1407552A (en) * 1973-04-02 1975-09-24 Science Union & Cie Disubstituted piperazines processes for their preparation and pharmaceutical compositions containing them
US4039676A (en) * 1975-06-23 1977-08-02 Ciba-Geigy Corporation 2-piperidinoalkyl-1,4-benzodioxans
US4468404A (en) * 1980-12-12 1984-08-28 Schering Corporation 3-Aralkyloxy-2,3-dihydro-2-(triazolymethyl)benzo(b)thiophenes
FI79535C (fi) * 1982-05-06 1990-01-10 Erba Farmitalia Foerfarande foer framstaellning av dihydrobensopyrans och dihydrobensotiopyrans substituerade iminoderivat.
GB8515389D0 (en) * 1985-06-18 1985-07-17 Ici Plc Heterocyclic compounds
ES2044970T3 (es) * 1986-06-26 1994-01-16 Ciba Geigy Ag Procedimiento para la obtencion de compuestos hidrogenados del acido 1-benzooxacicloalquil-piridincarboxilico.
US4801605A (en) * 1986-08-29 1989-01-31 Ciba-Geigy Corporation 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans
GB8704572D0 (en) * 1987-02-26 1987-04-01 Lundbeck & Co As H Organic compounds
JP2673024B2 (ja) * 1988-01-15 1997-11-05 アボツト・ラボラトリーズ アミノメチル‐クロマン及び‐チオクロマン化合物
DE69124868T2 (de) * 1990-08-15 1997-07-10 Lilly Co Eli Ring-substituierte 2-Amino-1,2,3,4-tetra-hydronaphthaline, 3-Aminochromane und 3-Aminothiochromane

Also Published As

Publication number Publication date
CA2012569A1 (fr) 1990-09-22
ATE121740T1 (de) 1995-05-15
IE901036L (en) 1990-09-22
FI94863B (fi) 1995-07-31
ES2071074T3 (es) 1995-06-16
FI94863C (fi) 1995-11-10
HUT53632A (en) 1990-11-28
PT93515B (pt) 1996-08-30
JPH037280A (ja) 1991-01-14
KR900014357A (ko) 1990-10-23
TW204347B (fr) 1993-04-21
IE67871B1 (en) 1996-05-01
GR3015938T3 (en) 1995-07-31
ZA902168B (en) 1990-11-28
IL93814A (en) 1995-07-31
IL93814A0 (en) 1990-12-23
EP0389425B1 (fr) 1995-04-26
EP0389425A1 (fr) 1990-09-26
DD292913A5 (de) 1991-08-14
PT93515A (pt) 1990-11-07
NO174669B (no) 1994-03-07
NO901303D0 (no) 1990-03-21
AU632318B2 (en) 1992-12-24
MX19953A (es) 1994-01-31
NZ233002A (en) 1992-07-28
DK0389425T3 (da) 1995-05-22
HU206205B (en) 1992-09-28
FI901371A0 (fi) 1990-03-19
AU5208690A (en) 1990-11-08
US5071858A (en) 1991-12-10
DE69018864D1 (de) 1995-06-01
NO901303L (no) 1990-09-24
JPH06102657B2 (ja) 1994-12-14
HU901636D0 (en) 1990-11-28

Similar Documents

Publication Publication Date Title
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
ATE7697T1 (de) Substituierte pyrazinyl-1,2,4-oxadiazol-5-one, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ATE103914T1 (de) Neue thienylcarbonsaeureester von aminoalkoholen, ihre quaternierungsprodukte sowie die herstellung und verwendung dieser verbindungen.
DE3887625D1 (de) Verfahren zur Herstellung von 1,1,1-Trifluorodichlorethan und von 1,1,1,2-Tetrafluorchlorethan.
ATE220400T1 (de) Trizyklische verbindungen zur behandlung von zellproliferativen störungen
NO902800L (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
DE59302501D1 (de) Substituierte Cyclohexan-Derivate, Verfahren zu ihrer Herstellung und die Anwendung der Verbindungen zur Behandlung von Krankheiten
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
NO174669C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzotiopyranylaminer
PT69999A (de) 1,2,3-triazolcarbonsaureamide verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
LU79376A1 (de) 1,2,3-thiadiazol-3-in-5-yliden-harnstoffe,verfahren zur herstellung dieser verbindungen sowie diese enthaltende mittel mit wachstumsregulatorischer wirkung
DE69026511D1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
ATE6643T1 (de) Neue 3,4-diaza-bicyclo(4.1.0)hepten-(2)-one-(5), verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel.
PT66339A (de) 1,2,3-thiadiazol-5-yl-harnstoffe,verfahren zur herstellung dieser verbindungen sowie diese enthaltende mittel zur wachstumsverzoegerung und zur entblaetterung von pflanzen
DE68901172D1 (de) (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend.
ATE100102T1 (de) Substituierte derivate von 20,21dinoreburnamenin, verfahren zur herstellung und so hergestellte zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen.
ATE106883T1 (de) Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten.
PT76582A (de) 1,2,4-triazol-1-yl-propionitrile verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
ATE195072T1 (de) Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen
ATE69809T1 (de) Leukotrienantagonisten, verfahren zu ihrer herstellung, ihre anwendung zur behandlung von krankheiten.
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
ATE57912T1 (de) Verfahren zur herstellung von anilinofumarat und 2,3-chinolindicarbonsaeure.
ATE66468T1 (de) Leukotrienantagonisten, verfahren zu ihrer herstellung und ihre anwendung zur behandlung von krankheiten.
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.